论文部分内容阅读
《Journal of Clinical Endocrinology&Metabolism》发表的一项研究结果显示,肥胖的糖尿病前期患者,减肥和增加体力活动或服用二甲双胍不仅可以降低他们进展为糖尿病的风险,也可能降低他们患心脏疾病的风险。该研究首次采用核磁共振(NMR)成像结合密度梯度离心(DGU)这两种方法证实,强化生活方式干预及使用二甲双胍,比安慰剂更能改善参
In a study published in the Journal of Clinical Endocrinology & Metabolism, obese patients with pre-diabetes, weight loss and increased physical activity or metformin not only reduced their risk of developing diabetes but also their risk of developing heart disease. The first study, using both nuclear magnetic resonance (NMR) imaging and density gradient centrifugation (DGU), confirmed that intensive lifestyle interventions and the use of metformin improved gastric perfusion better than placebo